Fig. 4From: Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitorsIGF-1R pathway is over expressed in HR deficient cancer cells. Cellular lysates from a) ovarian and b) breast cancer cells were subjected for western blot analysis for the indicated proteins involved in the IGF-1R pathway. One representative blot out of three is shownBack to article page